Our research group is focused on investigating the intricate mechanisms by which mechanobiology impacts cancer progression. Specifically, we aim to elucidate the influence of biochemical and mechanical signals arising from the tumor microenvironment, which have been shown to modulate the mechanical properties of cancer and stromal cells, and ultimately dictate cancer cell behavior, including migration and drug responses.
Our research goals are centered on identifying the molecular mediators that promote cancer cell survival and motility. Through a thorough exploration of these critical factors, we aspire to develop novel anti-cancer treatment strategies that may ultimately enhance patient outcomes.
May 17, 2023. Our first research article was published in MBoC. Congratulations to all authors!
March 17, 2023. Dr. Kim was awarded the GMaP Travel Funds to attend AACR Annual Meeting 2023.
Nov. 5, 2021. The Kim lab is now officially the mPI lab supported by the AIM Center.
Sept. 1, 2021. Dr. Mijung Oh joined the lab and was introduced in the AIM Core newsletter.
Feb. 4, 2021. Dr. Kim was awarded for the Metavivor Early Career Investigator Grant.
The Kim Lab is located in the Cancer Research Facility #209 @UNM.
The Kim Lab was officially established in August of 2020.